Clinical trial
A Single-institution, Parallel, Double-blinded, Randomized Study Assessing the Safety and Efficacy of Transdermal Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture Surgery
NCT06949826 is registered in ClinicalTrials.gov with Jenna-Leigh Wilson as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-institution, Parallel, Double-blinded, Randomized Study Assessing the Safety and Efficacy of Transdermal Buprenorphine as a Post-operative Analgesic in Opioid-Naive Patients After Ankle Fracture Surgery
- Lead sponsor
- Jenna-Leigh Wilson
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- April 21, 2025
- Completion date
- June 30, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ankle fracture surgery, opioid analgesia, opioid dependence, opioid use disorder, pain, postoperative